Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis — Dominik Bettinger (2018) | RDL Network
Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis
Article 2018 en
Authors
DB
Dominik Bettinger
DP
David J. Pinato
MS
Michael Schultheiß
Abstract
1 min read
In this retrospective comparative study, SBRT showed superior efficacy in HCC patients compared to patients treated with sorafenib.
Dominik Bettinger, David J. Pinato, Maximilian Schultheiß, Rishi Sharma, Lorenza Rimassa, Tiziana Pressiani, Michela Emma Burlone, Mario Pirisi, Masatoshi Kudo, J.W. Park, Nico Buettner, Christoph Neumann‐Haefelin, Tobias Boettler, N. Abbasi-Senger, H. Alheit, Wolfgang W. Baus, Oliver Blanck, S. Gerum, Matthias Gückenberger, Daniel Habermehl, C. Ostheimer, Oliver Riesterer, Jörg Tamihardja, A.-L. Grosu, Robert Thimme, Thomas Brunner, Eleni Gkika
Michael Buckstein, Edward Kim, Umut Özbek, Parissa Tabrizian, Ganesh Gunasekaran, Marcelo Facciuto, Kenneth E. Rosenzweig, Josep M. Llovet, Myron Schwartz
International Journal of Radiation Oncology*Biology*Physics
Pasquale Lombardi, Jung Sun Kim, Giulia Francesca Manfredi, Ciro Celsa, Claudia Angela Maria Fulgenzi, Antonio D’Alessio, Bernardo Stefanini, Nidhi Doshi, Emily Warmington, Thomas U. Marron, Matthias Pinter, Bernhard Scheiner, Beodeul Kang, Ho Yeong Lim, Wei‐Fan Hsu, Brooke Wietharn, Marianna Silletta, Alessandro Parisi, Chun‐Yen Lin, Andrea Dalbeni, Gianluca Masi, Martin Schönlein, Johann von Felden,
Discussion(0)
No comments yet. Be the first to comment.